Description: RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
Home Page: www.raysearchlabs.com
Sveavägen 44
Stockholm,
111 34
Sweden
Phone:
46 8 51 05 30 00
Officers
| Name | Title |
|---|---|
| Dr. Johan Lof | Founder, CEO, Pres & Director |
| Mr. Henrik Bergentoft | Chief Financial Officer |
| Mr. Kjell Eriksson | Head of Research & Chief Science Officer |
| Ms. Petra Jansson | Gen. Counsel |
| Mr. Peter Kemlin | Director of Sales & Marketing |
| Mr. Fredrik Lofman | Head of Machine Learning |
| Mr. Marc Mlyn CMD, MBA | Pres & CEO of RaySearch Americas |
Exchange: ST
Country: SE : Sweden
Currency: Swedish krone (kr)
| Forward PE: | 31.1526 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.1574 |
| Price-to-Sales TTM: | 2.8521 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 373 |